Charles River Laboratories International Inc $55.91

up +0.69


30/7/2014 04:08 PM  |  NYSE : CRL  
Industries : Health Services / Medical Laboratories & Research
Get Trend Analysis Icon Get CRL Trend Analysis - it has outperformed the S&P 500 by 8%

Partner Headlines

  1. John Rogers Comments on Charles River Laboratories Intl Inc

    GuruFocus
  2. John Rogers' Ariel Fund Second Quarter 2014 Commentary

    GuruFocus
  3. Charles River Aims To Be 'One-Stop Shop' With Buyout

    IBD
  4. Morgan Stanley Feels Confidence in Charles River Laboratories Following ...

    Benzinga
  5. CHARLES RIVER LABS

    IBD
  6. Earnings Scheduled For February 11, 2014

    Benzinga
  7. Parexel Plunges After 3 CROs Report Earnings

    IBD
  8. Parexel Stock Rises As Analyst Upgrades, Touts CROs

    IBD
  9. Medical Research Firms Tap Drug Development Trend

    IBD
  10. Medical Research Firms Tap Drug Development Trend

    IBD
  11. Earnings Scheduled For February 13, 2013

    Benzinga
  12. Robert Olstein's Largest New Stock Picks

    GuruFocus
  13. UPDATE: Sterne Agee Reiterates Buy Rating, Raises PT on Charles River Laboratories

    Benzinga
  14. Weekly CFO Sells HIGHLIGHT: TMO, BLOX, VRSK, CRL, INGR, GWRE

    GuruFocus
  15. Charles River Laboratories International Inc (CRL) Corp. ...

    GuruFocus
  16. Charles River Labs Closes Purchase of Majority Ownership of Vital River

    Benzinga
  17. UPDATE: JP Morgan Upgrades Charles River Laboratories to Overweight on ...

    Benzinga
  18. Mid-Afternoon Market Update: Bernanke Press Conference Leads to Drop in ...

    Benzinga
  19. Mid-Day Market Update: Fed to Continue Stimulus, Markets Rise

    Benzinga
  20. UPDATE: ISI Group Cuts PT to $39 on Charles River Laboratories Following ...

    Benzinga
  21. Top 4 NYSE Stocks In The Biotechnology Industry With The Highest ROA

    Benzinga
  22. Charles River Laboratories International Reports Operating Results (10-Q)

    GuruFocus
  23. UPDATE: Jefferies & Company Reiterates Hold Rating, Raises PT on Charles ...

    Benzinga
  24. Top 4 NYSE Stocks In The Biotechnology Industry With The Highest Revenue ...

    Benzinga
  25. Charles River Laboratories International (CRL) Chairman, President and ...

    GuruFocus
  26. Charles River Laboratories International (CRL) Chairman, President and ...

    GuruFocus
  27. Charles River Laboratories International (CRL) Corp. ...

    GuruFocus
  28. Charles River Opens New Biomedical Diagnostic Facility

    Benzinga
  29. Charles River Acquires Accugenix

    Benzinga
  30. Charles River Laboratories International Reports Operating Results (10-Q)

    GuruFocus
  31. Charles River Laboratories International (CRL) Corp. ...

    GuruFocus
  32. Charles River Laboratories International (CRL) Chairman, President and ...

    GuruFocus
  33. Charles River Laboratories International (CRL) Chairman, President and ...

    GuruFocus
  34. Charles River Laboratories International (CRL) Chairman, President and ...

    GuruFocus
  35. Charles River Laboratories International (CRL) Chairman, President and ...

    GuruFocus
  36. Health Care Sector Wrap

    FoxBusiness
  37. Charles River Laboratories International (CRL) Corp. ...

    GuruFocus
  38. Charles River Labs

    IBD
  39. Ariel Funds Top Buys: "We think like Halvorsen: CRL is a buy"

    GuruFocus
  40. Stocks I Can Buy Much Cheaper Than Halvorsen Did

    GuruFocus
  41. Ken Heebner Top Holdings: AAPL Is a Buy at $380

    GuruFocus
  42. Benzinga's M&A Chatter for Tuesday January 10, 2012

    Benzinga
  43. Charles River rises on sale talk

    IBD
  44. JP Morgan Reiterates BioMimetic Therapeutics Neutral

    Benzinga
  45. Citigroup Lowers PT on Charles River Laboratories to $31

    Benzinga
  46. UPDATE: Deutsche Bank Lowers PT on Charles River Laboratories to $28

    Benzinga
  47. Deutsche Bank Maintains Hold After Charles River Releases 2012 Guidance

    Benzinga
  48. Notable Call Options Activity in Charles River Laboratories

    Benzinga
Trading Center